Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Cash from Financing Activities (2020 - 2025)

Maxcyte (MXCT) has disclosed Cash from Financing Activities for 6 consecutive years, with $105000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 74.51% to $105000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $656000.0 through Dec 2025, down 68.09% year-over-year, with the annual reading at $656000.0 for FY2025, 68.09% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $105000.0 at Maxcyte, up from $14000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $184.6 million in Q3 2021, with the low at $14000.0 in Q3 2025.
  • Average Cash from Financing Activities over 5 years is $12.1 million, with a median of $428200.0 recorded in 2022.
  • The sharpest move saw Cash from Financing Activities surged 70325.91% in 2021, then crashed 99.76% in 2022.
  • Over 5 years, Cash from Financing Activities stood at $1.2 million in 2021, then grew by 1.52% to $1.2 million in 2022, then plummeted by 59.77% to $493000.0 in 2023, then fell by 16.43% to $412000.0 in 2024, then plummeted by 74.51% to $105000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $105000.0, $14000.0, and $154000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.